ArticleBiochemical genetics2026
Determination of the Frequency of HBB (c.20 A > T) Gene Mutation in the Nigerian and Zimbabwean Populations in Northern Cyprus.
Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell disease (SCD) is one of the most frequently observed monogenic diseases and is a major health problem worldwide. It is particularly prevalent in some countries such as Africa, the Middle East and the Mediterranean region. Due to a single point mutation in the β-globin gene HBB (c.20 A > T), the glutamic acid is replaced by valine amino acid at the sixth position of the β-globin chain (p.Glu6Val), which leads to changes in the properties of the hemoglobin protein and affects the conformation of red blood cells. Importantly, the distribution of the sickle hemoglobin (HbS) allele varies worldwide. Without knowing the distribution of this allele, the true significance of this gene mutation for SCD is unknown. The aim of this study is to determine the frequency of the HBB (c.20 A > T) gene mutation in the Nigerian and Zimbabwean populations in Northern Cyprus. Blood samples were collected from 208 volunteers (100 Nigerians and 108 Zimbabweans) living in Northern Cyprus. DNA was extracted from peripheral leukocytes. Genotyping was performed by real-time polymerase chain reaction (RT-PCR). The distribution of the allele and genotype frequencies of the HBB (c.20 A > T) gene mutation were tested for Hardy-Weinberg equilibrium. Notably, the distribution of the HBB (c.20 A > T) gene mutation in the Zimbabwean population was found to be in agreement with Hardy-Weinberg equilibrium (p > 0.05), suggesting a consistent allele frequency in this group. Particularly, the frequency of the HbS allele was determined to be 25% and 12.5% in the Nigerian and Zimbabwean populations, respectively. In summary, the results of this study have contributed to the literature by determining the frequency of the HBB (c.20 A > T) gene mutation in the Nigerian and Zimbabwean populations. This is crucial for understanding the true significance of this particular gene mutation for SCD in these two populations, which may also shed light on the development of better structured and preventive strategies.
Indexed as
Identifiers
41236685What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.